Obsidyan Logo

    Claim only what you have taught

    The wider your claim, the more your application must teach, so broaden only as far as your disclosure reaches.

    Lesson 2 of 9 · 4 min

    A vintage telegraph key drawn in fine lavender lines on top of a block of obsidian.

    The trade at the center of a patent

    A claim is the statement that defines what you own. The specification is what you teach. The two are tied together. The Supreme Court said in Amgen that the specification "must enable a person skilled in the art to make and use the entire class", and it gave the rule in one line: "The more one claims, the more one must enable" (Amgen v. Sanofi). A person skilled in the art is a working practitioner in the field.

    Morse, told correctly

    Samuel Morse claimed electromagnetism "however developed". The Court said he claimed "a manner and process which he has not described and indeed had not invented" (O'Reilly v. Morse).

    The story is often told wrong. Morse did not lose his patent. Only claim 8 fell, because separate claims protected him (O'Reilly v. Morse). In our judgment, that is the second lesson of the case: claims of different widths mean one overreach does not take down the rest.

    How broad is too broad

    In Incandescent Lamp, a claim to every fibrous material failed, and Edison's search through over 6,000 vegetable growths was what defeated it. The Court allowed that a genus, meaning a whole class of things, "might not be too broad" with "a quality common to them all" (Consolidated Electric Light v. McKeesport). So broadening needs a reason: a property that your data shows the members share.

    The other side of the line matters too. An inventor need not reach "the highest degree of perfection" if the patent "points out some practicable way" (The Telephone Cases). The Wright brothers' patent said expressly that their invention was not limited to the construction it showed (US 821,393).

    Two separate requirements

    Written description and enablement are separate (Teva v. Lilly). Written description shows possession, meaning you actually had the invention you claim (MPEP § 2163). Enablement means a skilled reader can make and use it without undue experimentation, assessed under Wands (MPEP § 2164).

    A working habit

    WIPO's drafting manual gives the practical rule: disclose "a working embodiment", a concrete version that works, and help the inventor consider alternatives, because inventors "often work to solve a very specific problem" (WIPO Patent Drafting Manual). Before you widen a claim, write down the variations you can actually teach.

    Timeless wisdom

    Patent scope is earned by teaching. Morse overreached when he claimed "a manner and process which he has not described and indeed had not invented" (O'Reilly v. Morse). A genus can stand when its members share "a quality common to them all" (Consolidated Electric Light v. McKeesport), and perfection is not required if the patent "points out some practicable way" (The Telephone Cases). Amgen carries the same line forward: "The more one claims, the more one must enable" (Amgen v. Sanofi).

    What's current

    As of November 6, 2026

    As of November 6, 2026, Amgen is running at full strength against compound and composition genus claims: Seagen v. Daiichi Sankyo (Dec. 2, 2025), Duke v. Sandoz, with no "blaze marks" to the claimed compounds (Nov. 18, 2025), and Wyeth v. AstraZeneca (July 9, 2026). Exelixis v. MSN is a counter-example on written description (Aug. 31, 2026).

    Teva v. Lilly (Apr. 16, 2026) distinguished Amgen for method claims using a well-known genus for a limited purpose, which is a narrow ruling (opinion). Rehearing by the full court was denied on September 30, 2026, over Judge Dyk's dissent that the panel "creates confusion" (order). Whether Lilly will seek Supreme Court review is an open question.

    Key takeaways

    • The more you claim, the more your application must teach.
    • Morse lost only claim 8, because separate claims protected him.
    • Broaden a claim only as far as your data shows a common property.
    • Written description and enablement are separate requirements.

    Check your understanding

    1. You tested five alloys and found that all of them share one property that makes your device work. You want to claim more than those five. What does *Incandescent Lamp* suggest?
    2. What actually happened to Morse's patent?

    Record your embodiments and alternatives

    Sources

    1. Amgen Inc. v. Sanofi (U.S.)
    2. O'Reilly v. Morse (U.S.)
    3. The Incandescent Lamp Patent (Consolidated Electric Light v. McKeesport) (U.S.)
    4. The Telephone Cases (U.S.)
    5. US Patent 821,393 (Wright brothers)
    6. Teva v. Lilly (Fed. Cir. Apr. 16, 2026)
    7. MPEP § 2163
    8. MPEP § 2164
    9. WIPO Patent Drafting Manual
    10. Seagen v. Daiichi Sankyo (Fed. Cir. Dec. 2, 2025)
    11. Duke v. Sandoz (Fed. Cir. Nov. 18, 2025)
    12. Wyeth v. AstraZeneca (Fed. Cir. July 9, 2026)
    13. Exelixis v. MSN (Fed. Cir. Aug. 31, 2026)
    14. Teva v. Lilly, order denying rehearing (Fed. Cir. Sept. 30, 2026)

    The Academy is general education, not legal advice, and reading it doesn't create an attorney-client relationship. Patent law and fees change, so check the linked sources and have a registered patent attorney or agent review your situation before you file. Obsidyan sells patent software, including AI drafting tools, so weigh what these lessons say about AI tools with that in mind.